Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil Patkar

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Indian Journal of Pathology & Microbiology|October 11, 2018
<i>BRAFV600E</i> mutation in hairy cell leukemia: A single-center experienceAsma Bibi, Shrutika Java, Shruti Chaudhary, et al.
Blood Advances|August 30, 2021
Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemiaHasmukh Jain, Manju Sengar, Vasu Babu Goli, et al.
European Journal of Haematology|June 12, 2012
Molecular basis of Wiskott-Aldrich syndrome in patients from IndiaSachin David, Giridhara Rao Jayandharan, Aby Abraham, et al.
Cytometry. Part B, Clinical Cytometry|July 20, 2024
Utility of leukocyte-associated immunoglobulin-like receptor-1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B-cell non-Hodgkin lymphomaAnu Singh, Jagruti Patil, Sitaram G Ghogale, et al.
Indian Journal of Pathology & Microbiology|February 15, 2017
Immunogenetics of chronic lymphocytic leukemiaNikhil Patkar, Nikhil Rabade, Pratibha Amare Kadam, et al.
International Journal of Hematology|September 3, 2020
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myelomaBhausaheb Bagal, Anant Gokarn, Sachin Punatar, et al.
Indian Journal of Cancer|August 8, 2018
Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial HospitalGaurav Narula, Maya Prasad, Shalini Jatia, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Indian Journal of Pathology & Microbiology|October 11, 2018
<i>BRAFV600E</i> mutation in hairy cell leukemia: A single-center experienceAsma Bibi, Shrutika Java, Shruti Chaudhary, et al.
Blood Advances|August 30, 2021
Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemiaHasmukh Jain, Manju Sengar, Vasu Babu Goli, et al.
European Journal of Haematology|June 12, 2012
Molecular basis of Wiskott-Aldrich syndrome in patients from IndiaSachin David, Giridhara Rao Jayandharan, Aby Abraham, et al.
Cytometry. Part B, Clinical Cytometry|July 20, 2024
Utility of leukocyte-associated immunoglobulin-like receptor-1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B-cell non-Hodgkin lymphomaAnu Singh, Jagruti Patil, Sitaram G Ghogale, et al.
Indian Journal of Pathology & Microbiology|February 15, 2017
Immunogenetics of chronic lymphocytic leukemiaNikhil Patkar, Nikhil Rabade, Pratibha Amare Kadam, et al.
International Journal of Hematology|September 3, 2020
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myelomaBhausaheb Bagal, Anant Gokarn, Sachin Punatar, et al.
Indian Journal of Cancer|August 8, 2018
Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial HospitalGaurav Narula, Maya Prasad, Shalini Jatia, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Pageof 9